Skip to main content

Smallpox

  • Chapter

Abstract

Smallpox, otherwise known as variola, was first described in ancient Chinese texts dating from the eleventh century B.C. The Chinese were the first to discover that purposeful inoculation of lesional material into the nose of the un infected was preventative of disease in the sixth century B.C. (1). Although the disease was officially eradicated in 1979, known stocks of the material have been maintained in biolabs located in Russia and the United States, where they pose a potential source of public health concern if subverted as biowarfare agents (2–5). Smallpox belongs to the Poxvirus group of double-stranded DNA containing viruses that includes vaccinia, molluscum contagiosum, and cowpox. The poxviruses are among the largest of all human viruses, attaining a maximum diameter of 300 nm, and possess characteristic rectangular or cylindrical outer capsids and a central DNA core (6).

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   119.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Breman J, Arita I. The confirmation and maintenance of smallpox eradication. N Engl J Med 1980; 303: 1263.

    Article  PubMed  CAS  Google Scholar 

  2. Breman J, Henderson D. Poxvirus dilemmas: Monkeypox, smallpox, and biologic terrorism. N Engl J Med 1998; 303: 556.

    Article  Google Scholar 

  3. Albert M, Ostheimer K, Breman J. The last smallpox epidemic in Boston and the vaccination controversy, 1901–1903. N Engl J Med 2001; 344: 375.

    Article  PubMed  CAS  Google Scholar 

  4. Wehrle P. A reality in our time: Certification of the global eradication of smallpox. J Infect Dis 1980; 242: 636.

    Google Scholar 

  5. Fenner F. Global eradication of smallpox. Rev Infect Dis 1982; 4: 916.

    PubMed  CAS  Google Scholar 

  6. Henderson D. Smallpox. Clinical and epidemiologic features. Emerg Infect Dis 1999; 5: 537.

    Article  PubMed  CAS  Google Scholar 

  7. Michelson H, Ikeda K. Microscopic changes in variola. Arch Dermatol Syph 1927; 15: 138.

    Google Scholar 

  8. Greenberg M. Complications of vaccination against smallpox. Am J Dis Child 1948; 76: 492.

    PubMed  CAS  Google Scholar 

  9. Sarkany I, Caron G. Cutaneous complications of smallpox vaccination. Trans St Johns Hosp Dermatol Soc 1962; 48: 163.

    PubMed  CAS  Google Scholar 

  10. Lane J, et al. Complications of smallpox vaccination, 1968: National surveillance in the United States. N Engl J Med 1968; 281: 1201.

    Article  Google Scholar 

  11. CDC. Smallpox vaccine adverse events among civilians United States, March 2003. MMWR 2003; 52: 201.

    Google Scholar 

Download references

Rights and permissions

Reprints and permissions

Copyright information

© 2007 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

(2007). Smallpox. In: Deadly Dermatologic Diseases. Springer, New York, NY. https://doi.org/10.1007/978-0-387-68858-9_27

Download citation

  • DOI: https://doi.org/10.1007/978-0-387-68858-9_27

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-0-387-25442-5

  • Online ISBN: 978-0-387-68858-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics